Robert M. Chanock
35Patents
14h-index
43Co-inventors
81Inventor score
Filing activity: Jun 18, 1975 → Nov 19, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4800078A | Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb | Human Necessities | 68 | Expired |
| US6184024A | Chimeric and/or growth-restricted flaviviruses | Emerging Cross-Sectional Technologies | 66 | Expired |
| US5922326A | Attenuated respiratory syncytial virus vaccine compositions | Chemistry; Metallurgy | 55 | Expired |
| US5762905A | Human neutralizing monoclonal antibodies to respiratory syncytial virus | Chemistry; Metallurgy | 55 | Expired |
| US3992522A | Temperature-sensitive recombinant mutant viruses and a process for producing same | Emerging Cross-Sectional Technologies | 48 | Expired |
| US4552758A | Human use of avian-human reassortants as vaccines for influenza A virus | Chemistry; Metallurgy | 46 | Expired |
| US6685942B1 | Human neutralizing monoclonal antibodies to respiratory syncytial virus | Emerging Cross-Sectional Technologies | 45 | Expired |
| US7488477B2 | Neutralizing monoclonal antibodies to respiratory syncytial virus | Chemistry; Metallurgy | 23 | Expired |
| US4571385A | Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors | Chemistry; Metallurgy | 22 | Expired |
| US6660273B2 | Chimeric vaccine against tick-borne encephalitis virus | Emerging Cross-Sectional Technologies | 16 | Expired |
| US4704275A | Vaccine against rotavirus diseases | Chemistry; Metallurgy | 15 | Expired |
| US8221759B2 | Neutralizing monoclonal antibodies to respiratory syncytial virus | Chemistry; Metallurgy | 15 | Active |
| US4927628A | Vaccine against rotavirus diseases and method of preparing same | Emerging Cross-Sectional Technologies | 14 | Expired |
| US4751080A | Vaccine against rotavirus diseases | Chemistry; Metallurgy | 14 | Expired |
| US4341870A | Cultivatable human rotavirus type 2 | Chemistry; Metallurgy | 13 | Expired |
| US7150984B2 | Attenuated human rotavirus vaccine | Chemistry; Metallurgy | 13 | Expired |
| US7364737B2 | Human neutralizing monoclonal antibodies to respiratory syncytial virus | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6497884B1 | Chimeric vaccine against tick-borne encephalitis virus | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6676936B1 | Chimeric and/or growth-restricted flaviviruses | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5882651A | Attenuated respiratory syncytial virus vaccine compositions | Chemistry; Metallurgy | 8 | Expired |
| US5911998A | Method of producing a virus vaccine from an African green monkey kidney cell line | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8778671B2 | Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus | Emerging Cross-Sectional Technologies | 3 | Active |
| US10058602B2 | Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus | Emerging Cross-Sectional Technologies | 3 | Active |
| US4552757A | Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus | Chemistry; Metallurgy | 2 | Expired |
| US5646033A | African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.